Uremic toxin (UT) (UT)

Uremic toxins are a heterogeneous group of compounds that accumulate in the blood and tissues of patients with declining kidney function, contributing to the clinical syndrome of uremia (Vanholder et al., 2003, PMID: 12527333). A major subset of these toxins is produced in the gut lumen through the metabolic activity of the intestinal microbiota, which breaks down dietary precursors into compounds like indoxyl sulfate, p-cresyl sulfate, and trimethylamine N-oxide (Meijers et al., 2011, PMID: 21831914). These gut-derived toxins are particularly problematic because they are often protein-bound, making them difficult to remove via conventional hemodialysis. In the systemic circulation, they promote oxidative stress, vascular calcification, and tubulointerstitial fibrosis, thereby accelerating the progression of chronic kidney disease (CKD) and increasing cardiovascular risk (Tang et al., 2015, PMID: 25533605). Therapeutic interventions targeting these toxins in the gut include oral adsorbents like AST-120, which physically bind the toxins or their precursors to prevent absorption, and biotic therapies aimed at shifting the microbiome toward a less toxigenic profile (Schulman et al., 2015, PMID: 25168838). By sequestering these solutes within the gastrointestinal tract, these treatments aim to reduce the systemic toxic burden and improve patient outcomes.

Other names

Gut-derived uremic toxinsUremic retention solutesNephrotoxinsProtein-bound uremic toxins (PBUTs)Microbial uremic metabolites

Gastrointestinal adsorption of uremic toxins and their precursors to prevent systemic absorption and promote fecal excretion.